Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
320.40Prev. Close
323.55Volume
309Total traded value
0.01 CrUpper Circuit
388.25Lower Circuit
258.85Fundamentals
| Market Cap | ₹100Cr |
| ROE | 9.91% |
| P/E Ratio(TTM) | 20.75 |
| EPS(TTM) | 15.59 |
| P/B Ratio | 1.39 |
| Dividend Yield | 0.31% |
| Industry P/E | 41.14 |
| Book Value | 232.39 |
| Debt to Equity | 0.14 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Samrat Pharmachem
Samrat Pharmachem Limited is a manufacturer and exporter of pharmaceutical chemicals, producing vital intermediates for both domestic and global industries. The company's vision is to help create a self-sustainable and compassionate environment, contributing positively to the society as a whole. In a highly competitive business environment, the company achieved a turnover of ₹28,158.12 lakhs for the financial year 2023-24.;
| Parent Organisation | Samrat Pharmachem Limited |
| Managing Director | Mr. Lalit Mehta |
| BSE Symbol | 530125 |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 70.13 | ||
| Neuland Laboratories | NA (0.00%) | 111.47 | ||
| Jubilant Pharmova | NA (0.00%) | 37.80 | ||
| Acutaas Chemicals | NA (0.00%) | 62.78 |